Back to Search
Start Over
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis
- Source :
- JAMA Cardiol, JAMA Cardiology. AMER MEDICAL ASSOC, JAMA Cardiology
- Publication Year :
- 2021
- Publisher :
- American Medical Association, 2021.
-
Abstract
- IMPORTANCE: Ventricular tachycardia (VT) is associated with high mortality in patients with cardiac sarcoidosis (CS), and medical management of CS-associated VT is limited by high failure rates. The role of catheter ablation has been investigated in small, single-center studies. OBJECTIVE: To investigate outcomes associated with VT ablation in patients with CS. DESIGN, SETTING, AND PARTICIPANTS: This cohort study from the Cardiac Sarcoidosis Consortium registry (2003-2019) included 16 tertiary referral centers in the US, Europe, and Asia. A total of 158 consecutive patients with CS and VT were included (33% female; mean [SD] age, 52 [11] years; 53% with ejection fraction [EF]
- Subjects :
- Adult
Male
medicine.medical_specialty
Sarcoidosis
medicine.medical_treatment
Electric Countershock
Catheter ablation
Cardiac sarcoidosis
Ventricular tachycardia
Fluorodeoxyglucose F18
Recurrence
Internal medicine
medicine
Humans
In patient
Mortality
Original Investigation
Inflammation
Ejection fraction
Medical treatment
business.industry
Myocardium
Heart
Stroke Volume
Middle Aged
Ablation
medicine.disease
Defibrillators, Implantable
Death, Sudden, Cardiac
Treatment Outcome
Positron-Emission Tomography
Multivariate Analysis
Cardiology
Catheter Ablation
Tachycardia, Ventricular
Heart Transplantation
Female
Radiopharmaceuticals
Cardiology and Cardiovascular Medicine
business
Cardiomyopathies
Anti-Arrhythmia Agents
Cohort study
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- JAMA Cardiol, JAMA Cardiology. AMER MEDICAL ASSOC, JAMA Cardiology
- Accession number :
- edsair.doi.dedup.....95a2692a98ffbb19aac53a56f677443b